false
OasisLMS
Login
Catalog
Kidney Week 2026 Early Program On-Demand - Advance ...
AAVs Targeting Different Parts of the Nephron
AAVs Targeting Different Parts of the Nephron
Back to course
[Please upgrade your browser to play this video content]
Video Transcription
Video Summary
Tobias Huber discussed AAV gene delivery for kidney diseases, emphasizing “endotyping”: identifying disease mechanisms in specific cells rather than relying only on histology. His team screened large AAV capsid libraries to find kidney-targeting vectors. One capsid selectively transduced glomerular endothelial cells across several species. Engineering it to express an IgG-cleaving bacterial protease protected mice from anti-GBM disease when given before disease onset and improved disease measures when administered afterward.<br /><br />Because podocytes are difficult to target, the team screened another library in mice with a leaky filtration barrier. They identified capsids that transduced diseased podocytes, including human podocytes in vitro; this work is ongoing.<br /><br />A separate screen identified an AAV that targets macula densa cells through a specialized anatomical route from nearby capillaries. The team used it to ablate these cells and study their physiological role.<br /><br />Huber noted that kidney AAV translation still requires further work on delivery routes, dosing, capsid design, and cross-species validation. Q&A explored potential applications and cell specificity.
Asset Caption
Tobias B. Huber, MD, FASN
Meta Tag
Speaker
Tobias Huber
Keywords
AAV gene delivery
kidney diseases
endotyping
glomerular endothelial cells
podocyte targeting
macula densa cells
Tobias Huber
×
Please select your language
1
English